Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer”: [Annals of Oncology 33 (2022) 57-66] : corrigendum - Novello, Silvia; Torri, V.; Grohé, Christian; Kurz, S.; Serke, M.; Wehler, T.; Meyer, A.; Ladage, D.; Geissler, M.; Colantonio, I.; Cauchi, C.; Stoelben, E.; et al. (Annals of oncology, 2022)
Online verfügbar: 25. Januar 2022, Artikelversion: 18. März 2022